NFL
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
Two JAMA studies identify plasma biomarkers correlating with CTE pathology, but validation hurdles remain before clinical use in sports and veteran care.
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
-
Cemdisiran Cuts Dosing to Four Shots a Year in Myasthenia Gravis
-
AbbVie Bets $2.5 Billion on DISCO’s Bispecific Platform to Expand Oncology Pipeline
-
US Loses Measles Elimination Status as Endemic Transmission Returns After 26 Years
-
Pandemic Disruptions Drove Excess Breast Cancer and Leukaemia Deaths Across 54 Nations
-
How Fed Cuts, Bank Competition and Deposit Insurance Could Crash High-Yield Savings Rates
-
How 401(k) Holders Can Automatically Cut Single-Stock Concentration Risk
-
California’s Financial Literacy Mandate: The 2031 Graduation Requirement Explained
-
Fixed Index Annuities: How Buffer, Floor, and Fee Structures Shift $400,000 Outcomes
-
No Surprises Act arbitration adds $8.39 billion to employer health‑plan costs in 2025
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992

